We are live on ! Find out more
UTMD icon

Utah Medical Products
UTMD

98 hedge funds and large institutions have $266M invested in Utah Medical Products in 2019 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 39 increasing their positions, 27 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

133% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 6

44% more repeat investments, than reductions

Existing positions increased: 39 | Existing positions reduced: 27

10% more capital invested

Capital invested by funds: $241M → $266M (+$25.2M)

7% more funds holding

Funds holding: 92 → 98 (+6)

1.32% more ownership

Funds ownership: 72.99% → 74.31% (+1.3%)

Holders
98
Holders Change
+6
Holders Change %
+6.52%
% of All Funds
2.13%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
39
Reduced
27
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Russell Investments Group
Russell Investments Group
United Kingdom
+$3.56M
2
BlackRock
BlackRock
New York
+$3.16M
3
RHJA
Rice Hall James & Associates
California
+$2.78M
4
AA
Ancora Advisors
Ohio
+$2.38M
5
Fidelity Investments
Fidelity Investments
Massachusetts
+$1.89M

Top Sellers

Rank Fund Capital Flow
1
Lazard Asset Management
Lazard Asset Management
New York
-$13.7M
2
Wells Fargo
Wells Fargo
California
-$1.07M
3
Man Group
Man Group
United Kingdom
-$343K
4
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$332K
5
TAM
THB Asset Management
Connecticut
-$289K
Name Holding Trade Value Shares
Change 		Change in
Stake
RhumbLine Advisers
51
RhumbLine Advisers
Massachusetts
$446K -$589 -7 -0.1%
DCM
52
Dupont Capital Management
Delaware
$417K +$367K +4,357 New
FHB
53
First Hawaiian Bank
Hawaii
$411K +$92.6K +1,100 +34%
DekaBank Deutsche Girozentrale
54
DekaBank Deutsche Girozentrale
Germany
$401K +$371K +4,403 New
New York State Common Retirement Fund
55
New York State Common Retirement Fund
New York
$383K -$7.41K -88 -2%
PIM
56
Penobscot Investment Management
Massachusetts
$383K – – –
Barclays
57
Barclays
United Kingdom
$378K +$249K +2,957 +299%
AllianceBernstein
58
AllianceBernstein
Tennessee
$373K +$8.42K +100 +3%
Deutsche Bank
59
Deutsche Bank
Germany
$368K -$146K -1,729 -31%
Marshall Wace
60
Marshall Wace
United Kingdom
$352K -$200K -2,377 -39%
Two Sigma Investments
61
Two Sigma Investments
New York
$346K +$304K +3,611 New
SCP
62
Seizert Capital Partners
Michigan
$342K -$24.5K -291 -8%
Invesco
63
Invesco
Georgia
$259K +$3.7K +44 +2%
Squarepoint
64
Squarepoint
New York
$239K +$210K +2,500 New
BIP
65
Brandes Investment Partners
California
$236K +$208K +2,468 New
Manulife (Manufacturers Life Insurance)
66
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$231K +$203K +2,412 New
Two Sigma Advisers
67
Two Sigma Advisers
New York
$230K – – –
Cambridge Investment Research Advisors
68
Cambridge Investment Research Advisors
Iowa
$227K -$98.8K -1,173 -33%
Goldman Sachs
69
Goldman Sachs
New York
$214K +$188K +2,232 New
AIG
70
American International Group
New York
$212K +$1.85K +22 +1%
SRAM
71
Stone Ridge Asset Management
New York
$201K +$177K +2,100 New
OSAM
72
O'Shaughnessy Asset Management
Connecticut
$199K – – –
MIM
73
MetLife Investment Management
New Jersey
$192K – – –
PAM
74
Panagora Asset Management
Massachusetts
$162K – – –
OAM
75
Oppenheimer Asset Management
New York
$153K +$13.3K +158 +11%
1 2
3
4 5

UTMD Hedge Fund Activity: Q2 2019 in Review

98 of the 4,605 institutional investors tracked by Wall St. Rank reported a position in Utah Medical Products (UTMD) for Q2 2019, worth a combined $266M — up 10% from $241M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new UTMD positions and 6 closed out — a net gain of 8 holders — while 39 added to existing stakes and 27 trimmed.

The largest buyer was Russell Investments Group, adding an estimated $3.56M. The largest seller was Lazard Asset Management, exiting entirely with an estimated $13.7M sold.

  • 98 institutional investors held Utah Medical Products (UTMD) as of Q2 2019, up from 92 in Q1 2019.
  • Funds reported $266M of Utah Medical Products stock for Q2 2019, up 10% quarter-over-quarter.
  • 14 funds opened new Utah Medical Products positions in Q2 2019 and 6 closed out, a net change of +8 holders.
  • The largest Utah Medical Products buyer in Q2 2019 was Russell Investments Group, an estimated $3.56M added.
  • The largest Utah Medical Products seller in Q2 2019 was Lazard Asset Management, an estimated $13.7M sold.

Based on aggregated 13F filings for Q2 2019.